Intelligence · Clinical Development
Pipeline search results
Programs matching “healthy” across our ClinicalTrials.gov index — phase, modality, sponsor, and trial IDs.
Quick answer
Showing 1,124 pipeline programs matching "healthy" from NovaPharmaNews Clinical Development Intelligence — phase, modality, sponsor, and ClinicalTrials.gov trial IDs.
Refine search
Search results
-
Pozelimab
Regeneron UK Limited
Healthy Volunteer
1 trial -
Pozelimab
Alnylam Netherlands B.V.
Healthy
1 trial -
Pramipexole Dihydrochloride
Teva Pharma GmbH
Healthy
2 trials -
Pravastatin sodium 80 mg tablets
Teva Pharma GmbH
Healthy
1 trial -
QRL-101 Dose A
BRIGHT MINDS BIOSCIENCES INC.
Healthy
1 trial -
Quemliclustat
Arcus Biosciences
Healthy Participants
1 trial -
RE-021, sparsentan
Travere Therapeutics
Healthy Subjects
1 trial -
REGN1033
Regeneron UK Limited
Healthy
1 trial -
REGN1033
Regeneron UK Limited
Healthy Volunteers
1 trial -
REGN1033 (SAR391786)
Regeneron UK Limited
Healthy Volunteers
3 trials -
REGN10933+REGN10987
Regeneron UK Limited
Healthy
1 trial -
REGN1154 or placebo
Regeneron UK Limited
Healthy Volunteers
1 trial -
REGN1193
Regeneron UK Limited
Healthy Volunteers
1 trial -
REGN13335
Regeneron UK Limited
Healthy Volunteers
1 trial -
REGN14284
Regeneron UK Limited
Healthy
1 trial -
REGN15160 (IV)
Regeneron UK Limited
Healthy
1 trial -
REGN17092
Regeneron UK Limited
Healthy Volunteers
1 trial -
REGN2009
Regeneron UK Limited
Healthy Volunteers
1 trial -
REGN20423
Regeneron UK Limited
Healthy Volunteer
1 trial -
REGN22044
Regeneron UK Limited
Healthy Volunteer
1 trial -
REGN2222
Regeneron UK Limited
Healthy Volunteers
1 trial -
REGN2222(SAR438584)
Regeneron UK Limited
Healthy Volunteers
1 trial -
REGN2477
Regeneron UK Limited
Healthy Volunteers
1 trial -
REGN3470-3471-3479
Regeneron UK Limited
Healthy Volunteers
1 trial
Frequently asked questions
What is the Clinical Development Intelligence Platform?
It is NovaPharmaNews pipeline intelligence hub covering 20,548 clinical development programs — not just a directory. It includes phase distribution dashboards, therapeutic area overviews, NDA/BLA watchlists, upcoming readouts, company pipeline rankings, competitive landscape maps, and personalized watchlists.
How does this compare to Evaluate Pharma or Citeline?
Like Evaluate Pharma and Citeline Trialtrove, we index ClinicalTrials.gov programs by sponsor, phase, and indication. Our platform adds cross-links to NovaPharmaNews company profiles, drug INN pages, patents, and congress readout calendars — improving crawl depth and reducing orphan program pages.
Where does pipeline data come from?
Program records derive from ClinicalTrials.gov and link to sponsor company profiles. Trial status and phase reflect registry data at last sync — verify on ClinicalTrials.gov before investment decisions. See our data sources page for attribution.
Can I follow a company or program for updates?
Yes — use the watchlist forms on this page to follow sponsors, individual programs, disease clusters, or therapeutic areas. Alerts use the same subscription infrastructure as our events intelligence hub.